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Abstract 
Background:  This study aimed to explain how quality of life changes during psychotherapy, 
using a cognitive-behavioural theoretical framework, and examined whether changes in 
symptoms or changes in cognitions were more influential with regard to quality of life 
change.  Three different hypotheses were tested that might explain the mechanisms by which 
QOL changes during group cognitive-behaviour therapy (CBT) for anxiety and depression.   
Methods: 127 outpatients with anxiety and depression enrolled in a four-week group CBT 
program participated. Measures of anxiety and depression symptoms, cognitive change, and 
quality of life were administered at baseline and post-treatment.  Baseline to post-treatment 
change scores were calculated and entered into multiple regression analyses.   
Results: Reductions in anxiety and depression symptoms were related to increases in quality 
of life, whereas cognitive changes were not consistently related to changes in quality of life.  
Limitations: The main limitation was that the study’s design was not able to assess whether 
changes in cognitions or symptoms preceded changes in QOL, as all variables were measured 
at the same two points in time.   
Conclusions:  These results provided evidence that quality of life changes as a result of or, 
simultaneously with, symptom change.  It appears that group CBT does not improve quality 
of life through strategies designed to change patients’ cognitions. 
 
Key words: quality of life, anxiety, depression, mechanisms of change, cognitive theory, 
component analysis, psychotherapy.  
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Exploring Mechanisms of Change: The Relationships Between Cognitions, Symptoms, 
and Quality of Life Over the Course of Group Cognitive-Behavior Therapy 
 The efficacy and effectiveness of cognitive-behaviour therapy (CBT) for anxiety and 
depression have been well supported by empirical research (Butler et al., 2006; DeRubeis and 
Crits-Christoph, 1998; Oei and Dingle, 2008; Oei and Boschen, 2009; Dwyer et al., 2013).  
However, at present, there is limited evidence in support of the specific mechanisms of 
change in CBT, and its impact on additional outcomes such as quality of life (QOL).  The 
present study aimed to investigate how changes in QOL relate to changes in cognitions and 
changes in symptoms over the course of group CBT. 
The evidence in support of cognitive change as the central mechanism of change in 
CBT appears to be limited and inconclusive.  Randomised controlled trials (RCTs), 
comparison studies, and process research studies have been criticised for their inability to 
delineate the processes and mechanisms of change in psychotherapy research (Hofmann, 
2008, Longmore and Worrell, 2007).  Treatment comparison studies and RCTs have revealed 
differential changes in cognitions between pharmacological and psychological treatments, 
despite equivalent efficacy, such that greater cognitive change was observed in CBT (Butler 
et al., 1991; DeRubeis et al., 1990; Rush et al., 1982).  However, other studies found no such 
differences (Simons et al., 1984; Zeiss et al., 1979).  There is also evidence that cognitive 
change may not be unique to CBT, as it has been found to occur as a result of 
pharmacotherapy and other psychological interventions (Longmore and Worrell, 2007; Oei 
and Free, 1995).  Furthermore, Longmore and Worrell (2007) presented some evidence that 
cognitive components of therapy do not actually add to its effectiveness and that challenging 
thoughts may be unnecessary.  This raises the question of whether cognitive change is 
necessary for therapy to be successful (i.e., to produce symptom improvement or especially 
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improved quality of life; Fayer & Machin, 2007) or whether it is simply a correlate or 
consequence of successful therapy.   
More recently, researchers have turned to mediation analyses to test the cognitive 
mediation model and to identify causal factors in CBT.  DeRubeis and Feeley (1990) 
examined the process of change in CBT among outpatients with major depression.  They 
utilised a temporal delay between assessments and found strong evidence for cognitive 
mediation.  A factor reflecting the “concrete” and specific cognitive change methods of CBT, 
measured at session two, predicted a later reduction in depression symptoms.  While Feeley 
et al. (1999) replicated this finding, it was not replicated in studies by independent 
researchers (Burns and Spangler, 2001; Jacobson et al., 1996).  More recently, Casey et al. 
(2005) reported that early change in panic severity during a CBT program was predicted by 
both catastrophic misinterpretation and self-efficacy cognitions, independently, using time 
period analyses in a cross-sectional study.  A number of other studies have found an 
association between reductions in symptoms and changes in maladaptive cognitions (Furlong 
and Oei, 2002; Khawaja and Oei, 1998; Casey et al., 2004 a, b).  However, there has been 
limited evidence as to the direction of causation in these studies.  Thus, the pervasive view of 
the mechanism of change in CBT, the cognitive mediation model, has become accepted 
despite a lack of strong empirical evidence (DeRubeis et al., 1990; Laurenceau et al., 2007).  
The available evidence highlights the need for further testing of the cognitive mediation 
model and the assumptions underpinning CBT. 
Of primary interest in this study was the question: Where does QOL fit in the 
cognitive models of anxiety and depression?  If the definition of treatment outcome is to be 
expanded to include improvements in QOL and subjective well-being (Frisch, 1994; Frisch, 
1998; Frisch et al., 1992; Quilty et al., 2003), it is imperative that research tests the way in 
which CBT produces such improvements through process studies.   
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One hypothesis is that the link between real life circumstances and life satisfaction 
may depend on how one appraises those circumstances (Eng et al., 2005; Frisch, 1998; 
Michalos, 1991).  Subjective life satisfaction is the accumulation of cognitive judgments 
comparing one’s actual life with one’s ideal life (Frisch, 1994; Gladis et al., 1999; 
McAlinden and Oei, 2006).  Using CBT to reduce negative thinking, challenge catastrophic 
future predictions, and increase positive modes of thinking may have a positive impact on 
patients’ subjective satisfaction with life.  That is, QOL may be cognitively mediated.  
However, the effects of positive, negative, or anxiety-provoking cognitions on life 
satisfaction have not been specifically addressed in a treatment outcome study.  Evidence 
exists that CBT may have an effect on QOL that is independent of symptom change.  In one 
study, treatment responders and non-responders each reported significant increases in their 
life satisfaction over the course of group CBT for social phobia (Safren et al., 1996).  That is, 
although one group experienced symptom reduction and the other did not, both experienced a 
statistically identical improvement in their QOL at post-treatment, which suggests that there 
may have been aspects of the intervention that improved QOL independently of symptom 
reduction.  In another study, Hirschfeld et al. (2002) treated patients with chronic depression 
with a combination of medication and CBT.  The combined treatment appeared to have had 
an independent effect on psychosocial functioning, even after controlling for improvements 
in depressive symptoms.   
Alternatively, individuals may become more satisfied with their lives because they are 
no longer feeling anxious or depressed post-treatment.  Some evidence exists in support of 
the hypothesis that improvements in QOL directly reflect improvements in the symptoms of a 
disorder, rather than being influenced by the specific intervention or cognitive change.  
However, it is important to note that this evidence focuses almost exclusively on panic 
disorder.  Reductions in anxiety, panic attack frequency, and avoidance following CBT or 
Mechanisms of QOL Change 
 
6 
 
pharmacotherapy, have been found to be related to improvements in both functioning and life 
satisfaction among patients with panic disorder (Jacobs et al., 1997; Pohl et al., 1998; Pollack 
et al., 1998; Telch et al., 1995).  Furthermore, Telch et al. (1995) found that changes in 
anxiety and avoidance predicted functioning at both post-treatment and six-month follow-up.  
However, other studies found no correlation between symptom reduction and QOL, both in 
panic disorder and obsessive-compulsive disorder (Michelson et al., 1998; Tenney et al., 
2003).      
The role of cognitive change in improving QOL has not been specifically addressed in 
an outcome study.  Furthermore, the existing evidence that change in QOL is directly related 
to symptom change is inconclusive and warrants further investigation.  This study attempted 
to address this gap in the literature by examining the relationships between changes in QOL, 
symptoms, and cognitions during group CBT.  We proposed three competing hypotheses 
regarding the relationship between QOL, cognitions, and symptoms:  
H1) change in QOL will be predicted by change in cognitions and not by change in 
symptoms;  
H2) change in QOL will be predicted by both cognitions and symptoms independently; 
H3) change in QOL will be predicted by change in symptoms but not by change in 
cognitions.  
Methods 
Participants 
 Participants were 127 patients who had completed four weeks of group CBT for 
anxiety or depression (see Dwyer et al 2013; Oei & Boschen 2009, 2006).  The anxiety group 
consisted of 86 patients (57 females, 29 males), whose ages ranged from 21 to 72 years (M = 
45.51; SD = 11.42).  The depression group consisted of 41 patients (25 females, 16 males), 
whose ages ranged from 19 to 67 years (M = 44.15; SD = 11.73).  Diagnoses were made 
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according to the DSM-IV-TR (American Psychiatric Association, 2000) based on a clinical 
interview with each patient’s treating psychiatrist. Patients were not excluded on the basis of 
comorbidity. Patients were referred to either a depression or anxiety CBT psychotherapy 
group based on their primary diagnosis. Primary diagnoses were Panic Disorder (52), 
Generalized Anxiety Disorder (23), and Post-Traumatic Stress Disorder (11) among those 
referred to anxiety groups, and Major Depressive Disorder (41) among those referred to 
depression groups. It is worth noting that independent sample t-tests indicated that the anxiety 
group was more severely impaired than the depression group at baseline on all indices except 
QOL, where the groups were comparable (see Tables 1 and 2). This is consistent with 
previous research which found that depression was associated with a more severe impairment 
in quality of life than anxiety (Rapaport, Clary, Fayyad & Endicott, 2005).  
Measures 
Quality of Life (QOL) 
The Quality of Life Inventory (Frisch, 1994) was used to assess domain-based life 
satisfaction. Patients rated 16 areas of life (e.g., health; money) in terms of importance (from 
0  “Not important” to 2 “Extremely important”) and current satisfaction (from -3 
“Dissatisfied” to +3 “Satisfied”). Responses were then weighted (importance x satisfaction) 
and summed to yield an overall score of -96 to +96. A higher score is indicative of higher 
quality of life. 
Symptoms 
Depression symptoms were measured using the Zung Self-Rating Depression Scale, 
which provides a validated indicator of the current behavioural, cognitive, somatic, and 
affective symptoms of depression (Gabrys & Peters, 1985; Zung, Richards, & Short, 1965). 
Patients responded to 20 items such as ‘I feel down-hearted and blue’ on a 4-point scale from 
‘A little of the time’ to ‘All of the time,’ which was then converted to an index score in 
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accordance with recommendations (Zung et al., 1965). A higher score is indicative of a more 
severe level of depression. In order to reduce conceptual overlap with our measures of 
depressive cognitions, the four items which assessed cognitive symptoms (e.g., “I feel 
hopeful about the future”) were removed from our index of depression symptoms.  
Anxiety symptoms were measured using the Beck Anxiety Inventory (Beck, Epstein, 
Brown, & Steer, 1988), which is a validated measure of the severity of clinical anxiety 
symptoms. Patients rate how bothered they have been by 21 symptoms such as ‘Heart 
pounding/racing’ in the past month on a 4-point scale from ‘Not at all’ to ‘Severely.’ Items 
are summed to obtain a total score ranging from 0 to 63. A higher score is indicative of a 
more severe anxiety. In order to reduce conceptual overlap with our measures of anxious 
cognitions, three items which assessed cognitive symptoms (e.g., “Fear of the worst 
happening”) were removed from our index of anxiety symptoms. 
Cognitions  
To assess depressive cognitions, we utilized the Sentence Completion test for 
Depression (Barton and Morley, 1999; Barton et al., 2005a). This measure allows participants 
to generate their own responses to neutral sentence stems (e.g. “I have…”, thereby allowing 
the assessment of negative self-focused cognitions. The SCD-Negative cognitions (SCD-N) 
score was determined in accordance in recommendations by calculating the percentage of 
items on the SCD-22 that were negative. 
To assess anxious and catastrophic cognitions, the 21-item Catastrophic Cognitions 
Questionnaire – Modified (CCQM; Khawaja et al., 1994) was used. This scale asks 
participants to rate how dangerous they perceive various emotional and physical sensations to 
be, such as “Feeling shaky”, on a 5 point scale from “Not at all dangerous” (1) to “Extremely 
dangerous” (5).  
Mechanisms of QOL Change 
 
9 
 
Procedure 
The University of Queensland and Toowong Private Hospital human research ethics 
committees approved the study.  All patients participated voluntarily after giving informed 
consent.  Patients undertook group CBT for anxiety or depression, which consisted of eight 3-
hour sessions over a four-week period (the high intensity was due to the hospital setting).  
The treatments were manualised and included psychoeducation, homework, group discussion, 
relaxation, cognitive restructuring, and relapse prevention strategies (Oei, 2002, a, b).  
Additionally, patients with depression engaged in activity scheduling and social skills 
training, while patients with anxiety participated in exposure exercises and behavioural 
experiments.  Sessions were conducted by a clinical psychologist and psychiatric nurse as co-
therapists.  Patients completed the questionnaire battery at baseline and post-treatment.  
Further details of the treatment protocol have been reported in a number of other studies (Oei 
and Browne, 2006; Oei and Boschen, 2009; Dwyer et al., 2013). 
Statistical Analyses 
Results were analysed separately for the anxiety and depression groups, as the groups 
received slightly different forms of group CBT. The baseline and post-treatment data were 
used to calculate change scores for each variable, denoted by delta (ǻ).  For the QOL, the 
baseline score was subtracted from the post-treatment score, whereas for all other outcome 
measures, the post-treatment score was subtracted from the baseline score – thus, for all 
measures positive ǻ represented a change associated with better wellbeing or mental-health. 
First, simple correlations between change scores were examined to identify significant 
bivariate relationships.  Second, the three hypotheses were tested using hierarchical multiple 
regression. Two analyses were run for each group – one including change in anxiety 
symptoms and anxious cognitions as predictors, and one including change in depressive 
symptoms and cognitions as predictors.  
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Results 
Anxiety Group 
 Patients in the anxiety group experienced positive and significant change on all 
outcome measures. The degree of improvement was modest for QOL (Cohen’s d = 0.31) and 
most pronounced for SCD-N (Cohen’s d = 0.94). Bivariate correlations of change scores for 
the anxiety group are presented in Table 3.  Changes in QOL measures were significantly 
related to changes in depression symptoms, changes in depressive symptoms, and changes in 
depressive cognitions.  
Test of the hypotheses.  The outcome of the hierarchical regression analyses for the 
anxiety group are shown in Table 4. With regard to change in QOL, ǻZung-SRDS and 
ǻSCD-N scores together significantly predicted 30% of the variance in ǻQOL, R =.30, 
F(2,66)=14.16, p<.001. Change in depressive symptoms significantly and uniquely predicted 
improvements in QOL (t(66)=4.501, p<.001), but changes in depressive cognitions did not 
(t(66)=0.74, p=.461). The combination of ǻBAI and ǻCCQM scores significantly predicted 
25% of the variance in ǻQOL, F(2,82)=13.98, p<.001. Change in anxiety symptoms 
significantly and uniquely predicted improvements in QOL (t(82)=5.28, p<.001). ǻCCQM 
also significantly predicted ǻQOL (t(82)=-2.38, p=.020). However, this effect was on the 
opposite direction to what was expected, with individuals who experienced less change in 
their anxious cognitions experiencing a greater improvement in their QOL.  
Overall, then, the results indicate that changes in depression, anxiety, and anxious 
cognitions were significant predictors of change in QOL scores for the anxiety group.. 
Therefore, hypothesis 1, which stated that change in QOL would be associated with change in 
cognitions and not symptoms, was not supported by any of the analyses. Hypothesis 2 
proposed that changes in cognitions and symptoms would be independently associated with 
ǻQOL. Depressive cognitions were non-significant, which is contrary to hypothesis 2. 
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Although anxious cognitions were a significant predictor of ǻQOL, this occurred in the 
opposite direction to what was expected. The fact that change in anxious cognitions was 
associated with a reduction in QOL, rather than an improvement, was not predicted by any of 
our hypotheses and is inconsistent with cognitive theory. Therefore hypothesis 2 was not 
supported. Hypothesis 3 stated that symptoms change, but not cognitive change, would 
predict ǻQOL. Change in depression and anxiety symptoms accounted for 25% and 22% of 
ǻQOL, respectively. This compared to depressive and anxious cognitions, which accounted 
for a much smaller 0.32% and 5.12% of the variance, respectively. Therefore the results for 
the anxiety group are most consistent with hypothesis 3.  
Depression Group 
Patients in the depression group experienced positive and significant change on all 
outcome measures. The degree of improvement was smallest (although still moderate) for 
anxiety symptoms (Cohen’s d = 0.44) and most substantial for CCQM (Cohen’s d = 0.76). 
Bivariate correlations of change scores for the depression group are presented in Table 5.  
Changes in QOL were significantly related to changes in depression and negative cognitions, 
but not to anxiety symptoms or anxious cognitions. 
Test of the hypotheses.  The outcome of the hierarchical regression analyses for the 
depression group are shown in Table 6. With regard to change in QOL, ǻZung-SRDS and 
ǻSCD-N scores together significantly predicted 45% of the variance in ǻQOL, 
F(2,29)=12.05, p<.001. Change in depressive symptoms significantly and uniquely predicted 
improvements in QOL (t(29)=4.01, p<.001), but changes in depressive cognitions did not 
(t(29)=1.68, p=.103). The combination of ǻBAI and ǻCCQM scores did not significantly 
predict ǻQOL, R =-.04, F(2,38)=0.18, p=.834. Neither change in anxiety symptoms 
(t(38)=0.24, p=.810) nor change in anxious cognitions (t(82)=0.46, p=.648) significantly 
predicted ǻQOL.  
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Overall, then, the results indicate that only changes in depression symptoms 
significantly predicted change in QOL scores for the depression group. Therefore, hypothesis 
1, which stated that ǻQOL would be associated with change in cognitions and not symptoms, 
was not supported by any of the analyses. Hypothesis 2 proposed that changes in cognitions 
and symptoms would be independently associated with ǻQOL. However, neither depressive 
nor anxious cognitions significantly predicted ǻQOL, which was contrary to the hypothesis. 
Hypothesis 3 stated that symptoms change, but not cognitive change, would predict change in 
QOL. Change in anxiety symptoms was a non-significant predictor, accounting for only .02% 
of the variance in ǻQOL. However, change in depression symptoms account for a large 30% 
of ǻQOL. This compared to depressive and anxious cognitions, which accounted for a much 
smaller 5.34% and .06% of the variance, respectively. Therefore the results for the depression 
group are most consistent with hypothesis 3.  
Discussion 
This study aimed to identify predictors of change in Quality of Life (QOL) and to 
make preliminary inferences as to the processes of symptom, cognitive, and QOL change 
during group CBT.  Cognitive models typically focus on symptom improvement (Beck, 1976; 
Beck et al., 1985; Casey et al., 2004, a, b; Clark, 1986). However, in recent years there has 
been an increasing focus on quality of life as an important indicator of therapeutic outcome. 
The current study advanced the literature by directly assessing whether improvements in 
quality of life are due to the effects of CBT in changing cognition or in changing symptoms. 
With regard to the anxiety group, increased QOL was significantly related to decreases in 
depression and anxiety symptoms, as well as increases (or at least less improvement) in 
anxious cognitions.  With regard to the depression group, improvements in QOL were 
significantly related to decreases in depression symptoms, but not to changes in anxiety 
symptoms or cognitions.  These results replicated previous research that has found symptom 
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change to be related to change in QOL (Jacobs et al., 1997, Pohl et al., 1998, Pollack et al. 
1998, Telch et al., 1995). This finding is consistent with the earlier finding of Oei, Bullack 
and Campbell (2006) where they showed that depression symptom change was more likely 
than cognitive change to influence the outcome of GCBT for treatment of depression. 
However, to our knowledge this is the first study to demonstrate that change in symptoms is 
superior to change in cognitions in predicting improvements in quality of life following CBT.  
We investigated three different hypotheses describing the relationships between these 
change scores. The results revealed that relationships between QOL change and changes in 
the symptoms of anxiety and (especially) depression were strong, while the relationship 
between QOL change and cognitive change was weak and, while significant for the anxiety 
group for anxious cognitions, the direction of the effect was opposite to that predicted by 
cognitive theory. This was inconsistent with Hypothesis 1 and 2. Hypothesis 3, which posited 
that symptom change but not cognitive change would predict QOL change, was the most 
consistent model for both groups of patients.  This model suggested that QOL is much more 
closely linked to symptoms, and that change in QOL might occur independent of cognitive 
change.  
One purpose of this study was to bridge the gap between the cognitive models of 
anxiety and depression and the research on psychopathology and QOL.  For QOL to be 
widely adopted as an outcome measure in CBT research, it is important that this construct fits 
adequately within the cognitive-behavioural theoretical framework.  Overall, the results 
suggested that QOL improvement is likely to be directly related to symptom change, but not 
directly to cognitive change. This suggests that CBT therapists might justifiably focus on 
achieving symptom improvement (and the behavioural components of CBT) in preference to 
cognitive change. These results are also consistent with increasing evidence that the cognitive 
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components of CBT (specifically, challenging thoughts) are not necessary to produce 
successful outcomes (Ahn & Wampold, 2001; Longmore & Worrell, 2007; Oei et al 2006).  
In fact, and unexpectedly, change in anxious cognitions was negatively related to 
change in QOL among the anxiety group. Although this effect was small, sensitivity analyses 
(e.g. controlling for initial symptoms and initial cognitive style; including cognitive 
symptoms in the symptom measures) confirmed that it is robust. We theorize that this may 
occur because people with anxiety who experienced a reduced belief that their anxiety 
symptoms were dangerous might have engaged in more behavioral exposure, which might 
have (in the short term) increased their discomfort and therefore led to reduced quality of life. 
If this were the case, we would expect the negative effects of cognitive change would be 
short-lived (assuming behavioral exposure was well-implemented and effective). However, 
this interpretation is speculative and the result remains to be replicated. 
Limitations 
Several limitations of the study can be identified – in particular, a structured 
diagnostic interview was not used, and our depressed sample was smaller and less severe in 
presentation than the anxiety group. Therefore, caution is warranted in generalizing the 
results of the depression group in particular. However, it is also possible that the study 
method more faithfully approximates actual clinical practice and patients presenting for 
treatment than a fully controlled protocol.  
As data collection was conducted on two occasions (baseline and post-treatment), and 
change scores were used, firm conclusions about causation cannot be made as no temporal 
precedence has been established (DeRubeis et al., 1990). DeRubeis et al. (1990) found 
evidence of cognitive mediation by using a design with a temporal delay between 
assessments of cognitions and symptoms.  Yet, other authors have reported the absence of a 
causal link between cognitive change and symptom change (Burns and Spangler, 2001; 
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Jacobson et al., 1996).  Regardless, the results obtained in this study provided consistent 
evidence against the hypothesis that cognitive change is the mechanism through which CBT 
achieves QOL change.   
In conclusion, this study quantified the relationships between change in symptoms, 
cognitions, and QOL, relationships that have not been widely researched to date.  While the 
results were mixed, changes in symptoms generally predicted changes in QOL, while change 
in cognitions did not. This adds to the growing body of evidence suggesting that the “active 
ingredient” of CBT may not be cognitive change. Rather, symptom improvement, however it 
is achieved, is associated with general improvements in wellbeing.  
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Table 1 
Descriptive statistics and bivariate correlations between variables at baseline for the anxiety 
group 
 
Mean SD Į 
Bivariate correlations 
2.  3.  4.  5.  
1. QOL -1.74 28.45 N/A -.42*** -.47*** -.28** -.56*** 
2. BAI 26.84 12.26 .91       .38*** .44*** .33** 
3. Zung-
SRDS 
52.59 10.17 .74         .25* .50*** 
4. CCQM 63.72 17.15 .93         .30* 
5. SCD-N 49.45 19.37 .76     
*pδǤͲͷǡ**pδͲǤͲͳǡ***pδͲǤͲͲͳǡBAI=Beck Anxiety Inventory, CCQM=Catastrophic 
Cognition Questionnaire – Modified, QOL=Quality of Life Inventory, SCD-N=Adapted 
Sentence Completion Test for Depression-Negative Cognitions Score, Zung-SRDS=Zung 
Self-Rating Depression Scale. 
Note. Zung-SRDS and BAI means are lower than in previous samples due to the removal of 
cognitive symptom items. Alpha reliabilities cannot be calculated for the QoL as these scores 
are indexed. 
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Table 2 
Descriptive statistics and bivariate correlations between variables at baseline for the 
depression group 
 
Mean SD Į 
Bivariate correlations 
2.  3.  4.  5.  
1. QOL 6.85  22.19  .12 -.22 .05 -.49** 
2. BAI 12.95 8.49 .88       .34* .49** .08 
3. Zung-
SRDS 
45.59 7.42 .75         .19 .59*** 
4. CCQM 49.44 13.69 .92         -.06 
5. SCD-N 36.09 17.08 .78        
*pδǤͲͷǡ**pδͲǤͲͳǡ***pδͲǤͲͲͳǡBAI=Beck Anxiety Inventory, CCQM=Catastrophic 
Cognition Questionnaire – Modified, QOL=Quality of Life Inventory, SCD-N=Adapted 
Sentence Completion Test for Depression-Negative Cognitions Score, Zung-SRDS=Zung 
Self-Rating Depression Scale. 
Note. Zung-SRDS and BAI means are lower than in previous samples due to the removal of 
cognitive symptom items. Alpha reliabilities cannot be calculated for the QoL as these scores 
are indexed. 
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Table 3 
Bivariate correlations between change variables for the anxiety group 
 ǻBAI ǻZung-
SRDS 
ǻCCQM ǻSCD-N 
ǻQOL .45***      .50*** -.03 .29* 
ǻBAI  .27*       .39***    .37** 
ǻZung-SRDS   .14      .41*** 
ǻSCD-N       .34** 
*pδǤͲͷǡ**pδͲǤͲͳǡ***pδͲǤͲͲͳǡBAI=Beck Anxiety Inventory, CCQM=Catastrophic 
Cognition Questionnaire – Modified, QOL=Quality of Life Inventory, SCD-N=Adapted 
Sentence Completion Test for Depression-Negative Cognitions Score, Zung-SRDS=Zung 
Self-Rating Depression Scale. 
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Table 4 
Unique predictors of change in quality of life scores for the anxiety group 
 
Unique predictors of ǻQOL 
ȕ t df p 
% 
variance 
(semi-
partial r2) 
Anxious symptoms 
and cognitions model      
ǻBAI .55 5.28 82 <.001 25.30% 
ǻCCQM -.25 -2.38 82 .020 5.18% 
Depressive 
symptoms and 
cognitions model      
ǻZung-SRDS .51 4.51 66 <.001 21.53% 
ǻSCD-N .08 0.74 66 .461 0.32% 
BAI=Beck Anxiety Inventory, CCQM=Catastrophic Cognition Questionnaire – Modified, 
QOL=Quality of Life Inventory, SCD-N=Adapted Sentence Completion Test for Depression-
Negative Cognitions Score, Zung-SRDS=Zung Self-Rating Depression Scale.  
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Table 5           
Bivariate correlations between change variables for the depression group 
 ǻBAI 
ǻZung-
SRDS ǻCCQM ǻSCD-N 
ǻQOL .05     .55*** .09   .39* 
ǻBAI  .34* .29 .10 
ǻZung-SRDS   -.03 .26 
ǻSCD-N    .24 
*pδǤͲͷǡ**pδͲǤͲͳǡ***pδͲǤͲͲͳǡBAI=Beck Anxiety Inventory, CCQM=Catastrophic 
Cognition Questionnaire – Modified, QOL=Quality of Life Inventory, SCD-N=Adapted 
Sentence Completion Test for Depression-Negative Cognitions Score, Zung-SRDS=Zung 
Self-Rating Depression Scale. 
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Table 6 
Unique predictors of change in quality of life scores for the depression group  
 Significant unique predictors of ǻQOL 
ȕ t df p % 
variance 
(semi-
partial r2) 
Anxious symptoms 
and cognitions 
model 
     
ǻBAI .04 0.24 38 .810 0.02% 
ǻCCQM .08 0.46 38 .648 0.06% 
Depressive 
symptoms and 
cognitions model      
ǻZung-SRDS .57 4.01 29 <.001 30.25% 
ǻSCD-N .24 1.68 29 .103 5.34% 
BAI=Beck Anxiety Inventory, CCQM=Catastrophic Cognition Questionnaire – Modified, 
QOL=Quality of Life Inventory, SCD-N=Adapted Sentence Completion Test for Depression-
Negative Cognitions Score, Zung-SRDS=Zung Self-Rating Depression Scale.  
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